12-10-2026 20:53 via medpagetoday.com

Are Concerns Over Avacopan Efficacy Overblown?

(MedPage Today) -- Avacopan (Tavneos), the complement pathway inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), appeared strongly effective in an Italian registry study--a step, maybe, toward setting to rest...
Read more »

Medical Industry news



Olympus shares suffer biggest drop since 2011 after FDA warning
Olympus shares plunge 13% after FDA warning
Cardiac Microcurrent Therapy Raises Eyebrows in Heart Failure
The Pope Has Cancer
AI Has a Darker Side in Healthcare, Expert Says
Antioxidant May Influence Brain Changes in Multiple Sclerosis, Study Suggests
Assisted Reproductive Technology Effective in Women With IBD
CVS to Pay $315M to Settle Justice Department Case Over Opioid Prescriptions
Bootleg Retatrutide Deaths? PMOS and Dementia; Weight-Loss Drug to Be Discontinued
Cardiac Implant ID-er; CVD Gaps by County; Gov. Asked to Act on Cardiology Lawsuit
Dementia Cases Rising; Tylenol's Effect on Brain Organoids; Early-Onset Alzheimer's
No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema
Can States Put the Brakes on Healthcare Spending?
Nipocalimab Benefits Hold Up at 2 Years in Teens With Myasthenia Gravis
Desktop versie